These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22230199)

  • 81. Applications of Connectivity Map in drug discovery and development.
    Qu XA; Rajpal DK
    Drug Discov Today; 2012 Dec; 17(23-24):1289-98. PubMed ID: 22889966
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Small-molecule modulators of 14-3-3 protein-protein interactions.
    Ottmann C
    Bioorg Med Chem; 2013 Jul; 21(14):4058-62. PubMed ID: 23266179
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Impact of Chemical Probes in Drug Discovery: A Pharmaceutical Industry Perspective.
    Garbaccio RM; Parmee ER
    Cell Chem Biol; 2016 Jan; 23(1):10-17. PubMed ID: 26933732
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening.
    Magee TV
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2461-8. PubMed ID: 25971770
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Challenges in profiling and lead optimization of drug discovery for methyltransferases.
    Horiuchi KY
    Drug Discov Today Technol; 2015 Nov; 18():62-8. PubMed ID: 26723894
    [TBL] [Abstract][Full Text] [Related]  

  • 86. New kids on the block: novel informatics methods for natural product discovery.
    Hufsky F; Scheubert K; Böcker S
    Nat Prod Rep; 2014 Jun; 31(6):807-17. PubMed ID: 24752343
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Elements of Translational Chemical Biology.
    Copeland RA; Boriack-Sjodin PA
    Cell Chem Biol; 2018 Feb; 25(2):128-134. PubMed ID: 29233521
    [TBL] [Abstract][Full Text] [Related]  

  • 88. "Pharmacoperone": what's in a word?
    Conn PM; Ulloa-Aguirre A; Janovick JA
    Pharmacol Res; 2014 May; 83():1-2. PubMed ID: 24269962
    [No Abstract]   [Full Text] [Related]  

  • 89. Understanding Protein-Protein Interactions: Essential Players in (Patho)physiology (Part 1).
    Wilson AJ; Gunning PT
    Chembiochem; 2016 Apr; 17(8):644-5. PubMed ID: 27027879
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Methods for docking small molecules to macromolecules: a user's perspective. 2. Applications.
    Campagna-Slater V; Therrien E; Weill N; Moitessier N
    Curr Pharm Des; 2014; 20(20):3360-72. PubMed ID: 23947644
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers.
    Lawson ADG; MacCoss M; Heer JP
    J Med Chem; 2018 May; 61(10):4283-4289. PubMed ID: 29140691
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Discovery of neuritogenic compound classes inspired by natural products.
    Dakas PY; Parga JA; Höing S; Schöler HR; Sterneckert J; Kumar K; Waldmann H
    Angew Chem Int Ed Engl; 2013 Sep; 52(36):9576-81. PubMed ID: 23733315
    [No Abstract]   [Full Text] [Related]  

  • 93. Identification of protein binding partners of small molecules using label-free methods.
    Saxena C
    Expert Opin Drug Discov; 2016 Oct; 11(10):1017-25. PubMed ID: 27554241
    [TBL] [Abstract][Full Text] [Related]  

  • 94. One size does not fit all: Challenging some dogmas and taboos in drug discovery.
    Chai CL; Mátyus P
    Future Med Chem; 2016 Jan; 8(1):29-38. PubMed ID: 26689236
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Epigenetic drug target deconvolution by mass spectrometry-based technologies.
    Noberini R; Bonaldi T
    Nat Struct Mol Biol; 2019 Oct; 26(10):854-857. PubMed ID: 31582842
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Expanding chemogenomic space using chemoproteomics.
    Jones LH
    Bioorg Med Chem; 2019 Aug; 27(15):3451-3453. PubMed ID: 31221609
    [TBL] [Abstract][Full Text] [Related]  

  • 97. SEC-TID: A Label-Free Method for Small-Molecule Target Identification.
    Salcius M; Bauer AJ; Hao Q; Li S; Tutter A; Raphael J; Jahnke W; Rondeau JM; Bourgier E; Tallarico J; Michaud GA
    J Biomol Screen; 2014 Jul; 19(6):917-27. PubMed ID: 24554445
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Fragments and hot spots in drug discovery.
    Vajda S; Whitty A; Kozakov D
    Oncotarget; 2015 Aug; 6(22):18740-1. PubMed ID: 26300051
    [No Abstract]   [Full Text] [Related]  

  • 99. New Modalities for Challenging Targets in Drug Discovery.
    Valeur E; Guéret SM; Adihou H; Gopalakrishnan R; Lemurell M; Waldmann H; Grossmann TN; Plowright AT
    Angew Chem Int Ed Engl; 2017 Aug; 56(35):10294-10323. PubMed ID: 28186380
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Targeted protein knockdown using small molecule degraders.
    Raina K; Crews CM
    Curr Opin Chem Biol; 2017 Aug; 39():46-53. PubMed ID: 28605671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.